LSM7 variants involving key amino acids for LSM complex function cause a neurodevelopmental disorder with

Matis Crespin1, Karine Siquier-Pernet2, Pauline Marzin1

  • 1AP-HP, Necker Enfants-Malades Hospital, Fédération de Génétique et Médecine Génomique, Service de Médecine Génomique des Maladies Rares, 75015 Paris, France.

HGG Advances
|October 18, 2024
PubMed

Insights

Genetic variants in the LSM7 gene are confirmed to cause a neurodevelopmental disorder. This condition is characterized by cerebellar atrophy, hypoplasia, and leukodystrophy in affected children.

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Background:

  • Cerebellar atrophy and hypoplasia are observed in children with cerebellar ataxias, developmental delay, and intellectual disability.
  • These neurological signs can be linked to hypo- or de-myelinating leukodystrophies.
  • Previous reports suggested LSM7 as a candidate disease gene based on two cases with homozygous variants.

Purpose of the Study:

  • To investigate the role of LSM7 gene variants in a patient presenting with neurodevelopmental defects, leukodystrophy, and cerebellar atrophy.
  • To confirm the etiological link between LSM7 gene disruption and this specific neurodevelopmental disorder.

Main Methods:

  • Clinical evaluation and neuroimaging (MRI) of the patient.
  • Genetic analysis to identify variants in the LSM7 gene.
  • Comparison with previously reported cases and functional data on LSM complex.

Main Results:

  • The patient harbored compound heterozygous missense variants in the LSM7 gene.
  • One identified variant was identical to a previously reported case; the other was at a functionally critical position.
  • Clinical and neuroimaging findings were consistent with previously described LSM7-related disorders.

Conclusions:

  • LSM7 gene disruption is confirmed to cause a neurodevelopmental disorder.
  • The disorder is characterized by leukodystrophy and cerebellar atrophy.
  • The findings support LSM7 as a significant genetic factor in pediatric neurological disorders.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
140
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.1K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
487
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
141.6K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.0K